Myeloid-specific transcriptional activation by murine myeloid zinc-finger protein 2
- *Osaka Bioscience Institute, 6-2-4 Furuedai, Suita, Osaka 565, Japan; and ‡Department of Genetics, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka 565, Japan
-
Communicated by Charles Weissmann, University of Zurich, Zurich, Switzerland (received for review November 14, 1997)
Abstract
Myeloid zinc finger protein 2 (MZF-2) is a zinc-finger transcription factor that is expressed in myeloid cells, particularly in the cells committed to the neutrophilic lineage. Here we examine the ability of murine MZF-2 (mMZF-2) to activate transcription. The mMZF-2 protein binds to a DNA element (MZF-binding site) through its zinc-finger domain. When the intact mMZF-2 was cotransfected with a reporter gene, it did not activate transcription. However, N-terminal deletion mutants greatly enhanced transcription specifically in myeloid cells. Furthermore, in an in vivo competition assay, the middle region of MZF-2 inhibited the mMZF-2-mediated transcription activation. These results suggest that mMZF-2 is a transcriptional factor that can specifically work in myeloid cells and can be divided into at least three functional domains. The N-terminal domain inhibits transactivation by masking the effect of the activation domain. The middle region recruits a coactivator, which is responsible for myeloid-specific transcriptional activation. The C-terminal zinc-finger domain functions as a DNA-binding domain.
Footnotes
-
↵ † Present address: Department of Biotechnology, Faculty of Engineering, Okayama University, 3-1-1 Tsushima-naka, Okayama, Okayama 700, Japan.
-
↵ § To whom reprint requests should be addressed. e-mail: nagata{at}genetic.med.osaka-u.ac.jp.
- ABBREVIATIONS:
- G-CSF,
- granulocyte colony-stimulating factor;
- G-CSFR,
- G-CSF receptor;
- LeR,
- leucine-rich region;
- MZF-2,
- myeloid zinc-finger protein 2;
- hMZF-2,
- human MZF-2;
- mMZF-2,
- murine MZF-2
- Copyright © 1998, The National Academy of Sciences





